시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 추간판 변성 질환 치료 시장 보고서(2025년)
Degenerative Disc Disease Treatment Global Market Report 2025
상품코드 : 1704095
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,387,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,232,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,077,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

추간판 변성 질환 치료 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 6.9%로 378억 6,000만 달러에 달할 것으로 예상됩니다. 예측 기간 중의 성장은 의료비 지출 증가, 최소침습 수술에 대한 수요 증가, 환자 교육 강화, 임상 연구 확대, 전 세계 척추 질환의 유병률 증가 등에 기인합니다. 예측 기간 중 주요 동향으로는 AI와 머신러닝의 통합, 재생의료의 발전, 최소침습수술의 발전, 웨어러블 기술, 맞춤형 임플란트용 3D 프린팅, 원격의료, 원격진료, 개인맞춤형 의료의 중요성 등이 있습니다.

스포츠 부상 발생률 증가는 향후 수년간 추간판 변성 질환 치료 시장의 성장을 가속할 것으로 예상됩니다. 스포츠 부상은 운동선수나 신체 활동을 하는 개인이 신체적 손상이나 외상을 입는 것을 의미하며, 종종 갑작스러운 충격, 과도한 사용, 부적절한 기술로 인해 발생합니다. 스포츠 부상 증가는 종종 참여율 증가, 더 엄격한 훈련 루틴, 경쟁 성과에 대한 더 강한 집중과 같은 요인과 관련이 있습니다. 추간판 변성 질환 치료는 추간판 퇴행이 선수의 운동 능력과 운동 능력에 영향을 미치는 경우, 만성 척추 통증 관리 및 기능 회복을 위해 활용됩니다. 예를 들어 2023년 11월 영국에 본사를 둔 보험 중개회사 Howden Group Holdings Ltd는 2022년 10월 부상으로 인해 선수들이 대회 전 평균 11.35일을 결장했으며, 2023년 1월에는 19.41일로 증가했다고 보고했습니다. 따라서 스포츠 부상 증가는 추간판 변성 질환 치료 시장의 확대에 박차를 가하고 있습니다.

추간판 변성 질환 치료 시장의 주요 기업은 추간판 부피를 늘리고 허리 통증을 완화하며 진통제에 대한 의존도를 줄여 환자의 예후를 개선하기 위해 주사용 추간판 세포 치료(IDCT)와 같은 혁신적인 치료법 개발에 주력하고 있습니다. 주사용 추간판 세포치료제(IDCT)는 증상이 있는 요추 퇴행성 디스크 질환을 위해 고안된 재생 치료법입니다. 예를 들어 2023년 2월 미국 바이오 제약회사 DiscGenics Inc.는 증상성 요추 퇴행성 디스크 질환을 대상으로 한 주사 가능한 추간판 세포 치료(IDCT)에 대해 FDA의 재생의료 첨단 의료 지정을 받았습니다. 이 첨단 치료법은 성인 환자의 디스크 조직에서 유래한 살아있는 전구세포 집단을 사용하며, 디스크의 부피를 증가시켜 허리 통증을 완화하고 환자의 진통제 복용을 줄이는 것을 목표로 합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Degenerative disc disease treatment encompasses various medical approaches designed to alleviate symptoms and enhance functionality in individuals with degenerative disc disease, a condition where the spinal discs lose their cushioning ability over time. Treatments may include physical therapy, pain management with medications, lifestyle changes, and, in some cases, surgical procedures like discectomy or spinal fusion to relieve nerve pressure and stabilize the spine.

The primary types of treatment for degenerative disc disease are conventional drugs and novel therapies. Conventional drugs involve standard medications used to manage symptoms, such as pain relievers and anti-inflammatory drugs. These medications can be administered orally or via injection and are utilized in various settings, including hospitals, ambulatory surgical centers, and orthopedic centers.

The degenerative disc disease treatment market research report is one of a series of new reports from The Business Research Company that provides degenerative disc disease treatment market statistics, including degenerative disc disease treatment industry global market size, regional shares, competitors with a degenerative disc disease treatment market share, detailed degenerative disc disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the degenerative disc disease treatment industry. This degenerative disc disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The degenerative disc disease treatment market size has grown strongly in recent years. It will grow from $27.07 billion in 2024 to $29.01 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to an aging population, a sedentary lifestyle, advances in medical technology, increased awareness, rising obesity rates, growing sports injuries, and healthcare access expansion.

The degenerative disc disease treatment market size is expected to see strong growth in the next few years. It will grow to $37.86 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to rising healthcare expenditure, growing demand for minimally invasive procedures, enhanced patient education, expanding clinical research, and rising global incidence of spine disorders. Major trends in the forecast period include integration of AI and machine learning, the development of regenerative medicine, advancements in minimally invasive surgery, wearable technology, 3D printing for custom implants, telemedicine, and remote consultations, and a focus on personalized medicine.

The increasing incidence of sports injuries is expected to drive the growth of the degenerative disc disease treatment market in the coming years. Sports injuries refer to physical damage or trauma sustained by athletes or individuals involved in physical activities, often caused by sudden impacts, overuse, or improper techniques. The rise in sports injuries is often linked to factors such as higher participation rates, more rigorous training routines, and a stronger focus on competitive performance. Degenerative disc disease treatment is utilized to manage chronic spinal pain and restore function when disc degeneration affects athletes' performance and mobility. For example, in November 2023, Howden Group Holdings Ltd, a UK-based insurance intermediary company, reported that injuries in October 2022 led to players being sidelined for an average of 11.35 days before tournaments, with this number increasing to 19.41 days by January 2023. Therefore, the growing number of sports injuries is fueling the expansion of the degenerative disc disease treatment market.

Leading companies in the degenerative disc disease treatment market are focusing on developing innovative therapies, such as injectable disc cell therapy (IDCT), to enhance patient outcomes by increasing disc volume, relieving low back pain, and reducing reliance on pain medications. Injectable disc cell therapy (IDCT) is a regenerative treatment designed for symptomatic lumbar degenerative disc disease. For instance, in February 2023, DiscGenics Inc., a US-based biopharmaceutical company, received FDA regenerative medicine advanced therapy designation for its injectable disc cell therapy (IDCT), which targets symptomatic lumbar degenerative disc disease. This cutting-edge therapy employs a live progenitor cell population derived from donated adult human intervertebral disc tissue. IDCT aims to boost disc volume, alleviate low back pain, and lessen the need for pain medication in affected patients.

In January 2023, Companion Spine LLC, a US-based spine care company, acquired Backbone SAS for an undisclosed amount. This acquisition is intended to enhance Companion's portfolio of medical implants for treating spine and back pain. Backbone SAS, based in France, specializes in developing and manufacturing medical devices for spine and back pain treatment.

Major companies operating in the degenerative disc disease treatment market are Pfizer Inc., Johnson And Johnson, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Medtronic plc, Amgen Inc., Baxter International Inc., B. Braun SE, Zimmer Biomet Holdings Inc., Arthrex Inc., Ferring B.V., Biocon Limited, Integra LifeSciences Holdings Corporation, NuVasive Inc., Globus Medical Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., LifeNet Health

North America was the largest region in the degenerative disc disease treatment market in 2024. The regions covered in the degenerative disc disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the degenerative disc disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The degenerative disc disease treatment market consists of revenues earned by entities by providing services such as medical consultations, surgical procedures, and post-treatment rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The degenerative disc disease treatment market also includes sales of spinal implants, orthopedic braces, pain relief medications, physical therapy equipment, and diagnostic imaging tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Degenerative Disc Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on degenerative disc disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for degenerative disc disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The degenerative disc disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Degenerative Disc Disease Treatment Market Characteristics

3. Degenerative Disc Disease Treatment Market Trends And Strategies

4. Degenerative Disc Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Degenerative Disc Disease Treatment Growth Analysis And Strategic Analysis Framework

6. Degenerative Disc Disease Treatment Market Segmentation

7. Degenerative Disc Disease Treatment Market Regional And Country Analysis

8. Asia-Pacific Degenerative Disc Disease Treatment Market

9. China Degenerative Disc Disease Treatment Market

10. India Degenerative Disc Disease Treatment Market

11. Japan Degenerative Disc Disease Treatment Market

12. Australia Degenerative Disc Disease Treatment Market

13. Indonesia Degenerative Disc Disease Treatment Market

14. South Korea Degenerative Disc Disease Treatment Market

15. Western Europe Degenerative Disc Disease Treatment Market

16. UK Degenerative Disc Disease Treatment Market

17. Germany Degenerative Disc Disease Treatment Market

18. France Degenerative Disc Disease Treatment Market

19. Italy Degenerative Disc Disease Treatment Market

20. Spain Degenerative Disc Disease Treatment Market

21. Eastern Europe Degenerative Disc Disease Treatment Market

22. Russia Degenerative Disc Disease Treatment Market

23. North America Degenerative Disc Disease Treatment Market

24. USA Degenerative Disc Disease Treatment Market

25. Canada Degenerative Disc Disease Treatment Market

26. South America Degenerative Disc Disease Treatment Market

27. Brazil Degenerative Disc Disease Treatment Market

28. Middle East Degenerative Disc Disease Treatment Market

29. Africa Degenerative Disc Disease Treatment Market

30. Degenerative Disc Disease Treatment Market Competitive Landscape And Company Profiles

31. Degenerative Disc Disease Treatment Market Other Major And Innovative Companies

32. Global Degenerative Disc Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Degenerative Disc Disease Treatment Market

34. Recent Developments In The Degenerative Disc Disease Treatment Market

35. Degenerative Disc Disease Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기